19.17
Dbv Technologies Adr (DBVT) 最新ニュース
How M&A Unlocked A Biotech Rebound In 2025— And What Comes Next? - Benzinga
Sidus Space, Starfighters Space And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Honeywell, Intuitive Machines And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Sahm
DBV Technologies (NASDAQ:DBVT) Shares Gap Down on Insider Selling - Defense World
European ADRs Started The Week Higher, Led By Biotech - Finimize
H.C Wainwright and Citizens Raise PT on DBV Technologies (DBVT) Following Phase 3 VITESSE Trial Result - Finviz
Stock Market Today 21.12.2025 - ts2.tech
HC Wainwright Boosts Earnings Estimates for DBV Technologies - Defense World
DBV Technologies (NASDAQ:DBVT) Given New $45.00 Price Target at Citizens Jmp - Defense World
DBV Technologies S.A. (NASDAQ:DBVT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
HC Wainwright Has Positive Outlook for DBVT FY2026 Earnings - Defense World
Birkenstock, Insmed And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
DBV Technologies (NASDAQ:DBVT) Sets New 12-Month High on Analyst Upgrade - Defense World
European Stocks On Wall Street Delivered Modest Moves For Investors - Finimize
Crude Oil Rises Over 1%; General Mills Earnings Top Views - Benzinga
Toro, DBV Technologies, Udemy, ABM Industries And Other Big Stocks Moving Higher On Wednesday - Benzinga
Citizens raises DBV Technologies stock price target to $45 on Viaskin Peanut success By Investing.com - ca.investing.com
Pre Market Movers: DBVT, YCBD, KYTX Set The Pace - RTTNews
Citizens raises DBV Technologies stock price target to $45 on Viaskin Peanut success - Investing.com UK
DBV Technologies receive positive results in key study with peanut patch - medwatch.com
Why Aditxt Shares Are Trading Higher By Around 63%; Here Are 20 Stocks Moving Premarket - Benzinga
Cantor Fitzgerald Upgrades DBV Technologies (NASDAQ:DBVT) to “Strong-Buy” - Defense World
DBV Technologies stock soars after positive Phase 3 trial results - Investing.com
DBV Technologies Reports Positive Phase 3 Trial Results - TipRanks
DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years - The Manila Times
DBV Technologies Announces Positive Topline Results from - GlobeNewswire
Peanut Allergy Patch For Kids? DBV Technologies Advances Toward FDA Filing - Sahm
DBV Technologies (NASDAQ:DBVT) Shares Gap DownTime to Sell? - MarketBeat
Micron Technology To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
This SiTime Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
DBV Technologies stock price target raised to $35 from $20 at H.C. Wainwright - Investing.com
DBV Technologies stock initiated with Overweight rating at Cantor Fitzgerald By Investing.com - Investing.com Nigeria
DBV Technologies stock initiated with Overweight rating at Cantor Fitzgerald - Investing.com
European Companies Trading In The US Notched Gains This Week - Finimize
What is DBV Technologies ADR (DBVT) Stock Return on Shareholders’ Capital? - setenews.com
Are Smart Investors Making the Right Decision? Snow Lake Resources Ltd (LITM) - setenews.com
Vivo Capital LLC Takes Position in DBV Technologies S.A. $DBVT - MarketBeat
Total assets of DBV Technologies SA Sponsored ADR – LSX:A40WEX - TradingView
DBV Technologies (NASDAQ:DBVT) Coverage Initiated at Guggenheim - Defense World
Check Out Netskope Inc (NTSK)’s Trade Data Rather Than the Analysts’ Views - Setenews
Taking on analysts’ expectations and winning: DBV Technologies ADR (DBVT) - setenews.com
DBV Technologies stock initiated with Buy rating at Guggenheim - Investing.com
12 Health Care Stocks Moving In Friday's Pre-Market Session - Sahm
Healthy Upside Potential: Safe Pro Group Inc (SPAI) - Setenews
European Drugmakers And Banks Put ADRs In The Green - Finimize
DBV Technologies S.A. (NASDAQ:DBVT) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
RFK Jr Rejects Early Exposure Theory On Rising Peanut Allergies, Says Aluminum-Based Vaccines Are The Reason - Sahm
European ADRs Slip As Gains And Losses Balance Out - Finimize
大文字化:
|
ボリューム (24 時間):